Delivery Order SPE2DB24D2003-SPE2DB25FXLP5
- Not listed
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,281.17 to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5mL) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $1,358.05 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adacel TDAP vaccine in 0.5 mL vials. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Adacel TDAP syringes (5-pack unit). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Adacel TDAP vaccine delivery supports the Department of...
- The Defense Logistics Agency awarded a $3,165.54 delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (5-pack) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,716.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of ADACEL TDAP vaccine vials (0.5mL). The delivery order, issued without set-aside designation, is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting the military health system's immunization...
- The Defense Logistics Agency awarded a $15,084.90 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on May 14, 2025, with completion scheduled for May 15, 2025. This non-set-aside contract employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under AmerisourceBergen's existing federal contract framework with the Defense Logistics...
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLP5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ML) on August 12, 2025, with a ceiling value of $1,940.71. This firm fixed price delivery order, which is not set-aside and will be completed by August 13, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The TDAP vaccine procurement reflects the company's extensive role as a critical federal vendor supplying brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare operations. As a competitively awarded contractor with demonstrated capability to fulfill federal requirements, AmerisourceBergen continues to serve as a primary pharmaceutical provider for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/12/25 |